SEC Form 4 · accession 0000920465-15-000086
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Mulroy
Officer — Chief Financial Officer
Period of report
Dec 21, 2015
Accepted (ET)
Dec 23, 2015 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $28.24 | Dec 21, 2015 | A | 41,500 | A | — | Dec 21, 2025 | Common Stock | 41,500 | 41,500 | D |
Explanation of responses
- F1This option represents a right to purchase a total of 41,500 shares of the Issuer's Common Stock one quarter of which shall be fully vested and exercisable on December 21, 2016, with the remaining 31,125 shares vesting monthly thereafter over the next three years.